Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MiMedx Group Q4 2023 Adj EPS $0.04 Misses $0.07 Estimate, Sales $86.83M Beat $85.05M Estimate

Author: Benzinga Newsdesk | February 28, 2024 05:05pm
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. The company reported quarterly sales of $86.83 million which beat the analyst consensus estimate of $85.05 million by 2.09 percent. This is a 16.75 percent increase over sales of $74.38 million the same period last year.

Posted In: MDXG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist